Lakefront Biotherapeutics N.V.

LKFT | NASDAQ

$31.94

-$0.34 (-1.05%)

Nov 2, 2026, 12:07 PM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025
Cash & Equivalents	135.9M	66.81M	87.87M	64.46M	71.67M
Short-Term Investments	2.1B	2.92B	2.91B	2.99B	3.02B
Long-Term Investments	211.32M	47.93M	46.81M	46.84M	46.93M
Other Long-Term Assets	80.73M	185.9M	198.55M	189.17M	188.85M
Receivables	56.27M	54.03M	53.2M	77.67M	87.84M
Inventory	n/a	17.69M	22.49M	22.95M	33.79M
Other Current Assets	12.5M	6.77M	5.61M	11.29M	42.17M
Total Current Assets	2.31B	3.06B	3.08B	3.16B	3.26B
Property-Plant & Equipment	n/a	76.95M	80.66M	105.62M	109.69M
Goodwill & Intangibles	750.35M	746K	848K	7.42M	216.58M
Total Long-Term Assets	1.04B	311.69M	327.06M	349.89M	562.91M
Total Assets	3.35B	3.37B	3.41B	3.51B	3.82B
Account Payables	66.32M	95.77M	32.62M	100.63M	133.18M
Deferred Revenue	n/a	32K	32K	230.12M	230.24M
Short-Term Debt	1.59M	n/a	n/a	n/a	n/a
Other Current Liabilities	1.43M	2.13M	117.51M	33.72M	36.87M
Total Current Liabilities	70.29M	100.42M	152.86M	366.56M	402.95M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	12.46M	13.79M	12.6M	26.31M	23.69M
Total Long-Term Liabilities	17.23M	18.64M	17.79M	698.39M	771.45M
Total Liabilities	87.52M	119.06M	170.65M	1.06B	1.17B
Total Debt	6.36M	6.44M	6.92M	7.5M	8.44M
Book Value	3.26B	3.25B	3.24B	2.45B	2.64B
Book Value Per Share	48.74	49.39	49.10	37.13	40.12
Common Stock	293.82M	293.94M	293.94M	293.94M	293.94M
Retained Earnings	233.86M	228.33M	210.58M	-577.74M	-380.8M
Comprehensive Income	4.82M	-5.89M	-5.64M	-6.23M	-6.32M
Shareholders Equity	3.25B	3.25B	3.24B	2.45B	2.64B
Total Investments	2.31B	2.96B	2.96B	3.03B	3.07B